AEON Biopharma Inc’s recent filing unveils that its Director FISCHER JOST acquired Company’s shares for reported $29250.0 on May 21 ’25. In the deal valued at $0.49 per share,60,000 shares were bought. As a result of this transaction, FISCHER JOST now holds 266,785 shares worth roughly $0.26 million.
Then, FISCHER JOST bought 60,000 shares, generating $30,360 in total proceeds. Upon buying the shares at $0.51, the Director now owns 206,785 shares.
Before that, FISCHER JOST bought 50,000 shares. AEON Biopharma Inc shares valued at $24,940 were divested by the Director at a price of $0.50 per share. As a result of the transaction, FISCHER JOST now holds 146,785 shares, worth roughly $0.14 million.
H.C. Wainwright initiated its AEON Biopharma Inc [AEON] rating to a Buy in a research note published on August 18, 2023; the price target was $18.
Price Performance Review of AEON
On Tuesday, AEON Biopharma Inc [AMEX:AEON] saw its stock jump 10.46% to $0.96. Over the last five days, the stock has gained 3.16%. AEON Biopharma Inc shares have fallen nearly -98.07% since the year began. Nevertheless, the stocks have fallen -97.53% over the past one year. While a 52-week high of $64.80 was reached on 01/03/25, a 52-week low of $0.38 was recorded on 04/11/25.
Levels Of Support And Resistance For AEON Stock
The 24-hour chart illustrates a support level at 0.8480, which if violated will result in even more drops to 0.7350. On the upside, there is a resistance level at 1.1060. A further resistance level may holdings at 1.2510.
How much short interest is there in AEON Biopharma Inc?
A steep rise in short interest was recorded in AEON Biopharma Inc stocks on 2025-10-31, dropping by 76902.0 shares to a total of 37337.0 shares. Yahoo Finance data shows the prior-month short interest on 2025-09-30 was 0.11 million shares. There was a decline of -205.97%, which implies that there is a negative sentiment for the stock.
